Polyphophazenes as anti-cancer drug carriers: From synthesis to application

被引：33

作者：

Akram, Muhammad ^{[1
]}

Wang, Li ^{[1
]}

Yu, Haojie ^{[1
]}

Amer, Wael A. ^{[1
]}

Khalid, Hamad ^{[1
]}

Abbasi, Nasir M. ^{[1
]}

Chen, Yongsheng ^{[1
]}

Saleem, Zain-ul-Abdin M. ^{[1
]}

Tong, Rongbai ^{[1
]}

机构：

[1] Zhejiang Univ, Dept Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China

来源：

PROGRESS IN POLYMER SCIENCE | 2014年 / 39卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Anti-cancer drug; Poly(organophosphazene); pH-responsiveness; Drug delivery system; LIVING CATIONIC-POLYMERIZATION; HIGH-MOLECULAR-WEIGHT; AMBIENT-TEMPERATURE POLYMERIZATION; RECENT RESEARCH PROGRESS; IN-VITRO CYTOTOXICITY; CONTROLLED-RELEASE; AMPHIPHILIC POLYPHOSPHAZENES; PHOSPHONITRILIC COMPOUNDS; MULTIDRUG-RESISTANCE; CLINICAL-EXPERIENCE;

D O I：

10.1016/j.progpolymsci.2014.07.009

中图分类号：

O63 [高分子化学（高聚物）];

学科分类号：

070305 ; 080501 ; 081704 ;

摘要：

Currently, most of administered anti-cancer drugs are low molecular weight compounds (as compare to polymers) and hydrophobic in nature. Such small molecular anti-cancer drugs possess fast clearance rate from the blood circulating system and have toxic side effects. Poly(organophosphazenes) have wide range of biomedical applications owing good biocompatibility, sustainability and degradability into non-toxic by-products. So, in this review, we have carefully selected such poly(organophosphazenes), which proved to be good anti-cancer drug carriers because of overcoming crucial issues related to the administration of anti-cancer drugs i.e. poor hydrophilicity, lack of cancer cells specificity, and fast clearance rate from blood circulating system. Thence, the main focus of this review is to highlight the advancement that have been achieved in the synthesis of poly(organophosphazenes) and their application in anti-cancer drug delivery system (DDS). (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：1987 / 2009

页数：23

共 50 条

[1] Exosomes as Drug Carriers in Anti-Cancer Therapy
Chen, Lan
Wang, Li
Zhu, Lingling
Xu, Zihan
Liu, Yanyang
Li, Zhixi
Zhou, Jin
Luo, Feng
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[2] Multifunctional and biodegradable polyphosphazenes for use as macromolecular anti-cancer drug carriers
Teasdale, Ian
Wilfert, Sandra
Nischang, Ivo
Brueggemann, Oliver
POLYMER CHEMISTRY, 2011, 2 (04) : 828 - 834
[3] Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery
Tuguntaev, Ruslan G.
Okeke, Chukwunweike Ikechukwu
Xu, Jing
Li, Chan
Wang, Paul C.
Liang, Xing-Jie
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (19) : 2857 - 2865
[4] METFORMIN - FROM ANTI-DIABETIC DRUG TO ANTI-CANCER DRUG
Markowicz-Piasecka, Magdalena
Huttunen, Kristiina M.
Mikiciuk-Olasik, Elzbieta
Mateusiak, Lukasz
Sikora, Joanna
ACTA POLONIAE PHARMACEUTICA, 2018, 75 (01): : 3 - 18
[5] Synthesis of anti-cancer targeted therapies drug tivozanib
Liu, Mingxing
Hu, Lixiu
Wang, Xianwen
Zhu, Hongda
ADVANCES IN CHEMICAL ENGINEERING, PTS 1-3, 2012, 396-398 : 1490 - 1492
[6] Stereocomplexed micelles based on polylactides with β-cyclodextrin core as anti-cancer drug carriers
Kost, Bartlomiej
Brzezinski, Marek
Cieslak, Marcin
Krolewska-Golinska, Karolina
Makowski, Tomasz
Socka, Marta
Biela, Tadeusz
EUROPEAN POLYMER JOURNAL, 2019, 120
[7] DRUG TO DRUG INTERACTIONS FROM THE NEWER ANTI-CANCER DRUGS
Gennari, Alessandra
BREAST, 2021, 59 : S34 - S34
[8] Anti-cancer drug - Preface
Bergmann-Leitner, ES
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (19)
[9] ANTIBODIES AS CARRIERS OF TOXINS OR ANTI-CANCER MOLECULES
不详
REVUE DU PRATICIEN, 1981, 31 (19): : 1415 - 1416
[10] TRANSLESION SYNTHESIS PATHWAY AS TARGET FOR ANTI-CANCER DRUG DESIGN
Korzhnev, Dmitry
PROTEIN SCIENCE, 2019, 28 : 42 - 42

← 1 2 3 4 5 →